{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:06:46Z","timestamp":1787166406285,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.clnesp.2021.04.020","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T12:58:19Z","timestamp":1620392299000},"page":"437-444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2481-3298","authenticated-orcid":false,"given":"Estefan\u00eda","family":"Alc\u00e1ntara-Alonso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Molinar-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas Alberto","family":"Gonz\u00e1lez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9782-2398","authenticated-orcid":false,"given":"Viridiana","family":"Alc\u00e1ntara-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Antonio","family":"Mu\u00f1oz-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Juan","family":"Lozano-Nuevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Rabindranath","family":"Ben\u00edtez-Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Mendoza-Portillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2021.04.020_bib1","article-title":"SARS-Cov-2 infection: response of human immune system and possible implications for the rapid test and treatment","volume":"84","author":"di Mauro Gabriella","year":"2020","journal-title":"Int Immunopharm"},{"key":"10.1016\/j.clnesp.2021.04.020_bib2","first-page":"50","article-title":"Epidemiology of COVID-19 (special issue: COVID-19 pandemic)","author":"Bulut","year":"2020","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.clnesp.2021.04.020_bib3","article-title":"The pathogenesis and treatment of the \u2018Cytokine Storm\u2019\u2019 in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.clnesp.2021.04.020_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104484","article-title":"Immune response in COVID-19: what do we currently know?","volume":"148","author":"Oliveira","year":"2020","journal-title":"Microb Pathog"},{"key":"10.1016\/j.clnesp.2021.04.020_bib5","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00688-13","article-title":"Trained immunity or tolerance: opposing functional programs induced in human monocytes after engagement of various pattern recognition receptors","volume":"21","author":"Ifrim","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.clnesp.2021.04.020_bib6","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2013-3092","article-title":"Toll-like receptor status in obesity and metabolic syndrome: a translational perspective","volume":"99","author":"Jialal","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnesp.2021.04.020_bib7","doi-asserted-by":"crossref","DOI":"10.2337\/dc11-2375","article-title":"Increased toll-like receptor activity in patients with metabolic syndrome","volume":"35","author":"Jialal","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnesp.2021.04.020_bib8","first-page":"81","article-title":"Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis","author":"Zheng","year":"2020","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.clnesp.2021.04.020_bib9","article-title":"The potential role of dyslipidemia in covid-19 severity: an umbrella review of systematic reviews","volume":"9","author":"Choi","year":"2020","journal-title":"J\u00a0Lipid and Atherosclerosis"},{"key":"10.1016\/j.clnesp.2021.04.020_bib10","article-title":"Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection","volume":"14","author":"Hariyanto","year":"2020","journal-title":"Diabetes and Metabolic Syndrome: Clin Res Rev"},{"key":"10.1016\/j.clnesp.2021.04.020_bib11","first-page":"152","article-title":"Triglyceride\/high-density lipoprotein cholesterol (TG\/HDL-C) index as a reference criterion of risk for metabolic syndrome (MetS) and low insulin sensitivity in apparently healthy subjects","volume":"153","author":"Baez-Duarte Bg Z-Gig-Drt-Rer-Vgp-Frctmrgod","year":"2017","journal-title":"Gac Med Mex"},{"key":"10.1016\/j.clnesp.2021.04.020_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjms.2017.03.032","article-title":"Triglyceride to high-density lipoprotein cholesterol ratio and cardiovascular events in diabetics with coronary artery disease","volume":"354","author":"Yang","year":"2017","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.clnesp.2021.04.020_bib13","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-018-0762-4","article-title":"Association between insulin resistance and the development of cardiovascular disease","volume":"17","author":"Ormazabal","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.clnesp.2021.04.020_bib14","series-title":"ENSANUT-MC","year":"2016"},{"key":"10.1016\/j.clnesp.2021.04.020_bib15","article-title":"Prevalencia de diabetes y descontrol glucemico en Mexico: resultados de la Ensanut 2016","volume":"62","author":"Basto-Abreu","year":"2020","journal-title":"Salud Publica Mex"},{"key":"10.1016\/j.clnesp.2021.04.020_bib16","doi-asserted-by":"crossref","DOI":"10.21149\/10520","article-title":"Dyslipidemia prevalence, awareness, treatment and control in Mexico: results of the Ensanut 2012","volume":"62","author":"Hern\u00e1ndez-Alcaraz","year":"2020","journal-title":"Salud Publica Mex"},{"key":"10.1016\/j.clnesp.2021.04.020_bib17","article-title":"Coronavirus resource center","author":"Mortality Analyses","year":"2021","journal-title":"Johns Hopkins University and Medicine"},{"issue":"9","key":"10.1016\/j.clnesp.2021.04.020_bib18","article-title":"SARS-CoV-2 viremia is associated with inflammatory, but not cardiovascular biomarkers, in patients hospitalized for COVID-19","volume":"10","author":"Myhre","year":"2021","journal-title":"J\u00a0Am Heart Ass"},{"issue":"2","key":"10.1016\/j.clnesp.2021.04.020_bib19","first-page":"388","article-title":"Thrombo-inflammatory biomarkers in COVID-19: systematic review and meta-analysis of 17,052 patients","volume":"5","author":"Chaudhary","year":"2021","journal-title":"Mayo Clin Proc: Innovations, Quality & Outcomes"},{"key":"10.1016\/j.clnesp.2021.04.020_bib20","doi-asserted-by":"crossref","DOI":"10.7150\/ijms.46614","article-title":"Factors associated with death outcome in patients with severe coronavirus disease-19 (Covid-19): a case-control study","volume":"17","author":"Pan","year":"2020","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.clnesp.2021.04.020_bib21","first-page":"13","article-title":"Outcomes in patients with COVID-19 disease and high oxygen requirements","author":"Rojas-Marte","year":"2021","journal-title":"J\u00a0Clin Med Res"},{"issue":"2","key":"10.1016\/j.clnesp.2021.04.020_bib22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.7861\/clinmed.2020-0688","article-title":"National Early Warning Score 2 (NEWS2) to identify inpatient COVID-19 deterioration: a retrospective analysis","volume":"21","author":"Baker","year":"2021","journal-title":"Clin Med"},{"key":"10.1016\/j.clnesp.2021.04.020_bib23","doi-asserted-by":"crossref","DOI":"10.1186\/s13049-020-00764-3","article-title":"National Early Warning Score 2 (NEWS2) on admission predicts severe disease and in-hospital mortality from Covid-19 - a prospective cohort study","volume":"28","author":"Myrstad","year":"2020","journal-title":"Scand J Trauma Resuscitation Emerg Med"},{"key":"10.1016\/j.clnesp.2021.04.020_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.resuscitation.2020.10.039","article-title":"The performance of the National Early Warning Score and National Early Warning Score 2 in hospitalised patients infected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"159","author":"Kostakis","year":"2021","journal-title":"Resuscitation"},{"key":"10.1016\/j.clnesp.2021.04.020_bib25","article-title":"Ferritin levels and COVID-19","volume":"44","author":"Vargas-Vargas","year":"2020","journal-title":"Revista Panamericana de Salud Publica\/Pan American Journal of Public Health"},{"key":"10.1016\/j.clnesp.2021.04.020_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.amsu.2021.02.009","article-title":"Evaluation of serum ferritin for prediction of severity and mortality in COVID-19- A cross sectional study","volume":"63","author":"Ahmed","year":"2021","journal-title":"Annals of Med and Surg"},{"key":"10.1016\/j.clnesp.2021.04.020_bib27","doi-asserted-by":"crossref","DOI":"10.5847\/wjem.j.1920-8642.2021.01.003","article-title":"Identifying critically ill patients at risk of death from coronavirus disease","volume":"12","author":"Guo","year":"2021","journal-title":"World J Emergency Med"},{"key":"10.1016\/j.clnesp.2021.04.020_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-020-01382-9","article-title":"Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study","volume":"19","author":"Wang","year":"2020","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.clnesp.2021.04.020_bib29","article-title":"Cholesterol metabolism\u2014impacts on SARS-CoV-2 infection prognosis","author":"Peng","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.clnesp.2021.04.020_bib30","article-title":"Metabolic disturbances and inflammatory dysfunction predict severity of coronavirus disease 2019 (COVID-19): a retrospective study","author":"Nie","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.clnesp.2021.04.020_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.584987","article-title":"Lipid profile features and their associations with disease severity and mortality in patients with COVID-19","volume":"7","author":"Sun","year":"2020","journal-title":"Frontiers in Cardiovasc Med"},{"key":"10.1016\/j.clnesp.2021.04.020_bib32","article-title":"COVID-19\u2014associated dyslipidemia: implications for mechanism of impaired resolution and novel therapeutic approaches","volume":"34","author":"Sorokin","year":"2020","journal-title":"FASEB (Fed Am Soc Exp Biol) J"},{"key":"10.1016\/j.clnesp.2021.04.020_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/s12865-016-0180-x","article-title":"Lipoproteins attenuate TLR2 and TLR4 activation by bacteria and bacterial ligands with differences in affinity and kinetics","volume":"17","author":"van Bergenhenegouwen","year":"2016","journal-title":"BMC Immunol"},{"key":"10.1016\/j.clnesp.2021.04.020_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/ni.2784","article-title":"High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3","volume":"15","author":"de Nardo","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.clnesp.2021.04.020_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237062","article-title":"Nutritional status positively impacts humoral immunity against its Mycobacterium tuberculosis, disease progression, and vaccine development","volume":"15","author":"Niki","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.clnesp.2021.04.020_bib36","first-page":"1866","article-title":"Cholesterol, lipoproteins, and COVID-19: basic concepts and clinical applications","author":"Ko\u010dar","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.clnesp.2021.04.020_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00323","article-title":"High-density lipoproteins and apolipoprotein A-I: potential new players in the prevention and treatment of lung disease","volume":"7","author":"Gordon","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.clnesp.2021.04.020_bib38","doi-asserted-by":"crossref","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnesp.2021.04.020_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2020.00184","article-title":"Coronavirus and obesity: could insulin resistance mediate the severity of covid-19 infection?","volume":"8","author":"Finucane","year":"2020","journal-title":"Frontiers in Public Health"},{"key":"10.1016\/j.clnesp.2021.04.020_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001356","article-title":"Relationships between hyperinsulinaemia, magnesium, vitamin D, thrombosis and COVID-19: rationale for clinical management","volume":"7","author":"Cooper","year":"2020","journal-title":"Open Heart"},{"key":"10.1016\/j.clnesp.2021.04.020_bib41","doi-asserted-by":"crossref","DOI":"10.2337\/db05-1543","article-title":"Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans","volume":"55","author":"Stegenga","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.clnesp.2021.04.020_bib42","article-title":"Low serum cholesterol level among patients with COVID-19 infection in wenzhou, China","author":"Hu","year":"2020","journal-title":"SSRN Electronic J"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457721001625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457721001625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:00:48Z","timestamp":1762498848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457721001625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":42,"alternative-id":["S2405457721001625"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2021.04.020","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2021.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}